This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Myocardial infarction (MI), stroke, peripheralarterialdisease (PAD), heartfailure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.
Journal of the American Heart Association, Ahead of Print. Prevalence of hypertension (86.6%), heartfailure (22.7%), diabetes (54.8%), chronic kidney disease (23.6%), and chronic obstructive pulmonary disease (35.4%) was high. A majority of patients were current (27.1%) or former (30.0%) smokers. At 1 year, 9.4%
American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: HeartFailure Reveals that Despite Significant Efforts to Improve Acute HeartFailure Treatment Over the Past 20 Years, Management Remains Unchanged 3.
In this week’s View, Dr. Eagle looks at the recently released guideline for lower extremity peripheralarterialdisease (PAD). He then examines a national community-based cohort study on contemporary decongestion strategies in patients hospitalized for heartfailure.
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheralarterydisease and diabetes.
The article also includes links to DAIC channels (on peripheralarterydisease, stroke, heartfailure, peripheralarterydisease, cardiovascular clinical studies, and more) focused on specific areas of news coverage. per 1,000* - 122.4
Aims Patients experiencing ischaemic heartfailure with reduced ejection fraction (HFrEF) represent a diverse group. Association between clusters and the composite of (i) heartfailure hospitalization or all-cause death, (ii) cardiovascular (CV) hospitalization or all-cause death, and (iii) major adverse CV events was assessed.
In this week’s View, Dr. Eagle covers various blood pressure parameters and their predictability for peripheralarterialdisease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers.
We identified the subset of variables most predictive of post‐HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, heartfailure, stroke, atrial fibrillation or flutter, and sustained ventricular tachycardia.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Specifically, this genetic factor was found to lower the risk of type 2 diabetes by 46.5%, coronary heartdisease by 37.5%, ischemic stroke by 35.4%, cardiac-related mortality by 28.6%, heartfailure by 28.2%, transient ischemic attack by 24%, atrial fibrillation by 15.2%, peripheralarterydisease by 0.3%, and hypertension by 0.3%.
Results Brandenburg patients with cardiovascular diseases showed higher Lp(a) levels than healthy controls (24.2% vs. 14.8%, p = 0.001), and the high-Lp(a) group demonstrated a higher prevalence of coronary arterydisease, peripheralarterydisease, or cerebrovascular disease than the low-Lp(a) group ( p = 0.004).
Up to a third of patients went on to develop heart or kidney failure, 7% had further heart attacks and 38% died from any cause within the nine-year study period.
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheralarterydisease and diabetes.
Furthermore, knowledge regarding the management of paraspinal mycotic aneurysms and the efficacy of endovascular repair of these lesions is scarce.⁴MethodsWe
This unique case highlights the diagnostic and therapeutic challenges of a patient with multiple vascular risk factors who suffered from strokes secondary to BHS.MethodsA 79‐year‐old man with a past medical history of peripheralarterydisease, abdominal aortic aneurysm, myocardial infarction with drug eluding stents (on dual antiplatelet therapy (DAPT)), (..)
Resistance exercise also appears to be safe and effective for adults with heartfailure, peripheralarterialdisease (PAD), HIV, Alzheimer’s disease and dementia, and chronic kidney disease, among other conditions — for whom the benefits are likely much greater than those for adults without known diseases.
Resistance exercise also appears to be safe and effective for adults with heartfailure, peripheralarterialdisease (PAD), HIV, Alzheimer’s disease and dementia, and chronic kidney disease, among other conditions — for whom the benefits are likely much greater than those for adults without known diseases.
Journal of the American Heart Association, Ahead of Print. BackgroundSparce data suggest higher mortality in heartfailure (HF) with left ventricular ejection fraction (EF) >65% to 70%. We characterized EF distribution, characteristics, and outcomes in patients with HF and EF 50%.Methods
AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heartfailure (HF), chronic kidney disease (CKD), and peripheralarterydisease (PAD).
Models were adjusted for age, sex, race, ethnicity, heartfailure, coronary arterydisease, peripheralarterydisease, hypertension, diabetes, and tobacco use. Cox models were used to compare stroke recurrence in patients with multi-territory versus single-territory infarction.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content